Fisher Center Foundation For Alzheimer's Research
Alzheimer's research donation - Only 8% overhead
Donate Now to Alzheimer's  

ABOUT US    COMMUNITY    GET INVOLVED    E-NEWSLETTER    CONTACT US    PRESERVING YOUR MEMORY MAGAZINE    ASK THE EXPERTS
Select Text Size: a a a
Search  Go
         
Home > About Alzheimer's and Dementia > Understanding Alzheimer's Disease > Creutzfeldt-Jakob Disease

Creutzfeldt-Jakob Disease

Creutzfeldt-Jakob disease (CJD) is a rare, degenerative, invariably fatal brain disorder. It affects about one person in every one million people per year worldwide; in the United States there are about 200 cases per year. CJD usually appears in later life and runs a rapid course. Typically, onset of symptoms occurs about age 60, and about 90 percent of patients die within 1 year. In the early stages of disease, patients may have failing memory, behavioral changes, lack of coordination and visual disturbances. As the illness progresses, mental deterioration becomes pronounced and involuntary movements, blindness, weakness of extremities, and coma may occur.

Other types of Dementias

 Dementia with Lewy Bodies

 Frontotemporal Dementia

 Huntington's Disease

 Normal Pressure Hydrocephalus

 Parkinson's Disease

 Vascular Dementia

 Wernicke-Korsakoff Syndromep

 
 
 

Credits/Terms of Service/Privacy Policy/Alzheimer's Glossary/Contact Us/Request a Brochure/501 C 3 Letter /Site Map
ALZinfo.org Media Kit

ALZinfo.org's Social Networking Sites
ALZTalk.org      Facebook     Twitter     Myspace     YouTube     Squidoo

Please Help Support Alzheimer's Research Today!

© 2002 - 2010, a 501c3 not for profit, Tax ID # 13-3859563,
The Fisher Center for Alzheimer's Research Foundation
One Intrepid Square, West 46th Street & 12th Avenue, New York, NY 10036


This project was supported, in part, by a grant, number 90AZ2791, from the Administration on Aging, Department of Health and Human Services, Washington, D.C. 20201. Grantees undertaking projects under government sponsorship are encouraged to express freely their findings and conclusions. Points of view or opinions do not, therefore, necessarily represent official Administration on Aging policy.